Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination

Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):445. doi: 10.25259/IJDVL_819_2021.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / prevention & control
  • ChAdOx1 nCoV-19* / adverse effects
  • Herpes Zoster* / chemically induced
  • Herpes Zoster* / diagnosis
  • Herpesvirus 3, Human
  • Humans
  • Vaccination / adverse effects

Substances

  • ChAdOx1 nCoV-19